448 related articles for article (PubMed ID: 36284437)
1. Gut bacterial profiles in Parkinson's disease: A systematic review.
Li Z; Liang H; Hu Y; Lu L; Zheng C; Fan Y; Wu B; Zou T; Luo X; Zhang X; Zeng Y; Liu Z; Zhou Z; Yue Z; Ren Y; Li Z; Su Q; Xu P
CNS Neurosci Ther; 2023 Jan; 29(1):140-157. PubMed ID: 36284437
[TBL] [Abstract][Full Text] [Related]
2. Gut Microbiota and Its Repercussion in Parkinson's Disease: A Systematic Review in Occidental Patients.
Proano AC; Viteri JA; Orozco EN; Calle MA; Costa SC; Reyes DV; German-Montenegro M; Moncayo DF; Tobar AC; Moncayo JA
Neurol Int; 2023 Jun; 15(2):750-763. PubMed ID: 37368331
[TBL] [Abstract][Full Text] [Related]
3. Gut Microbiota Composition in Patients with Neurodegenerative Disorders (Parkinson's and Alzheimer's) and Healthy Controls: A Systematic Review.
Heravi FS; Naseri K; Hu H
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892440
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the gut microbiota of short-term and long-term medical workers and non-medical controls: a cross-sectional analysis.
Zheng N; Li SH; Dong B; Sun W; Li HR; Zhang YL; Li P; Fang ZW; Chen CM; Han XY; Li B; Zhang SY; Xu M; Zhang GX; Xin Y; Ma YF; Wan XY; Yan QL
Clin Microbiol Infect; 2021 Sep; 27(9):1285-1292. PubMed ID: 33160036
[TBL] [Abstract][Full Text] [Related]
5. The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection.
Romani L; Del Chierico F; Macari G; Pane S; Ristori MV; Guarrasi V; Gardini S; Pascucci GR; Cotugno N; Perno CF; Rossi P; Villani A; Bernardi S; Campana A; Palma P; Putignani L;
Front Cell Infect Microbiol; 2022; 12():908492. PubMed ID: 35873161
[TBL] [Abstract][Full Text] [Related]
6. What Are the Key Gut Microbiota Involved in Neurological Diseases? A Systematic Review.
Bonnechère B; Amin N; van Duijn C
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430144
[TBL] [Abstract][Full Text] [Related]
7. Core gut microbiota in Jinhua pigs and its correlation with strain, farm and weaning age.
Yang H; Xiao Y; Wang J; Xiang Y; Gong Y; Wen X; Li D
J Microbiol; 2018 May; 56(5):346-355. PubMed ID: 29721832
[TBL] [Abstract][Full Text] [Related]
8. Structural changes of gut microbiota in Parkinson's disease and its correlation with clinical features.
Li W; Wu X; Hu X; Wang T; Liang S; Duan Y; Jin F; Qin B
Sci China Life Sci; 2017 Nov; 60(11):1223-1233. PubMed ID: 28536926
[TBL] [Abstract][Full Text] [Related]
9. Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis.
Li F; Ye J; Shao C; Zhong B
Lipids Health Dis; 2021 Feb; 20(1):22. PubMed ID: 33637088
[TBL] [Abstract][Full Text] [Related]
10. Systematic Review of Gut Microbiota and Major Depression.
Cheung SG; Goldenthal AR; Uhlemann AC; Mann JJ; Miller JM; Sublette ME
Front Psychiatry; 2019; 10():34. PubMed ID: 30804820
[No Abstract] [Full Text] [Related]
11. Analysis of Gut Microbiota in Patients with Parkinson's Disease.
Petrov VA; Saltykova IV; Zhukova IA; Alifirova VM; Zhukova NG; Dorofeeva YB; Tyakht AV; Kovarsky BA; Alekseev DG; Kostryukova ES; Mironova YS; Izhboldina OP; Nikitina MA; Perevozchikova TV; Fait EA; Babenko VV; Vakhitova MT; Govorun VM; Sazonov AE
Bull Exp Biol Med; 2017 Apr; 162(6):734-737. PubMed ID: 28429209
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review.
Farsi Y; Tahvildari A; Arbabi M; Vazife F; Sechi LA; Shahidi Bonjar AH; Jamshidi P; Nasiri MJ; Mirsaeidi M
Front Cell Infect Microbiol; 2022; 12():804644. PubMed ID: 35310853
[TBL] [Abstract][Full Text] [Related]
13. Meta-Analysis of Gut Dysbiosis in Parkinson's Disease.
Nishiwaki H; Ito M; Ishida T; Hamaguchi T; Maeda T; Kashihara K; Tsuboi Y; Ueyama J; Shimamura T; Mori H; Kurokawa K; Katsuno M; Hirayama M; Ohno K
Mov Disord; 2020 Sep; 35(9):1626-1635. PubMed ID: 32557853
[TBL] [Abstract][Full Text] [Related]
14. Colonic bacterial composition in Parkinson's disease.
Keshavarzian A; Green SJ; Engen PA; Voigt RM; Naqib A; Forsyth CB; Mutlu E; Shannon KM
Mov Disord; 2015 Sep; 30(10):1351-60. PubMed ID: 26179554
[TBL] [Abstract][Full Text] [Related]
15. Changes in Gut Microbiota and Multiple Sclerosis: A Systematic Review.
Ordoñez-Rodriguez A; Roman P; Rueda-Ruzafa L; Campos-Rios A; Cardona D
Int J Environ Res Public Health; 2023 Mar; 20(5):. PubMed ID: 36901634
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota Dysbiosis Associated With Altered Production of Short Chain Fatty Acids in Children With Neurodevelopmental Disorders.
Bojović K; Ignjatović ÐI; Soković Bajić S; Vojnović Milutinović D; Tomić M; Golić N; Tolinački M
Front Cell Infect Microbiol; 2020; 10():223. PubMed ID: 32509596
[TBL] [Abstract][Full Text] [Related]
17. Dysbiosis of the Beneficial Gut Bacteria in Patients with Parkinson's Disease from India.
Pavan S; Gorthi SP; Prabhu AN; Das B; Mutreja A; Vasudevan K; Shetty V; Ramamurthy T; Ballal M
Ann Indian Acad Neurol; 2023; 26(6):908-916. PubMed ID: 38229613
[TBL] [Abstract][Full Text] [Related]
18.
Chu C; Yu L; Li Y; Guo H; Zhai Q; Chen W; Tian F
Nutrients; 2023 Apr; 15(7):. PubMed ID: 37049578
[TBL] [Abstract][Full Text] [Related]
19. Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease.
Chen SJ; Chen CC; Liao HY; Lin YT; Wu YW; Liou JM; Wu MS; Kuo CH; Lin CH
Neurology; 2022 Feb; 98(8):e848-e858. PubMed ID: 34996879
[TBL] [Abstract][Full Text] [Related]
20. Alteration of the fecal microbiota in Chinese patients with Parkinson's disease.
Qian Y; Yang X; Xu S; Wu C; Song Y; Qin N; Chen SD; Xiao Q
Brain Behav Immun; 2018 May; 70():194-202. PubMed ID: 29501802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
